Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis During Radiotherapy for Head and Neck Cancer

REFERENCES

• Argiris A, Karamouzis MV, Raben D, and Ferris RL: Head and neck cancer. Lancet 17, 1695–1709, 2008.
   Web of Science ®Google Scholar
• Pignon JP, le Maître A, Maillard E, Bourhis J, and MACH-NC Collaborative Group: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92, 4–14, 2009.
   PubMed Web of Science ®Google Scholar
• Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, et al.: Burden of Illness Head and Neck Writing Committee Cancer: patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 15, 2704–2713, 2008.
   Web of Science ®Google Scholar
• Elting LS, Cooksley CD, Chambers MS, and Garden AS: Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68, 1110–1120, 2007.
   PubMed Web of Science ®Google Scholar
• Russo G, Haddad R, Posner M, and Machtay M: Radiation treatment breaks and ulcerative mucositis in head and neck cancer. The Oncologist 13, 886–898, 2008.
   PubMed Web of Science ®Google Scholar
• Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, et al.: Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66, 253–262, 2003.
   PubMed Web of Science ®Google Scholar
• Lalla RV, Sonis ST, and Peterson DE: Management of oral mucositis in patients who have cancer. Dent Clin North Am 52(1), 61–77, 2008.
   PubMedGoogle Scholar
• Hidayat H, Karsten K, Viqar UA, Ghulam AM, and Ivan RG: Lapachol: an overview. Arkivoc 2, 145–171, 2007.
   Google Scholar
• Maorong S, Hasegawa I, Hikaru K, Fumihide T, and Tomihisa O: Anti-inflammatory constituents from Tabebuia avellanedae. Fitoterapia 83, 1484–1488, 2012.
   PubMed Web of Science ®Google Scholar
• Byeon SE, Chung JY, Lee YG, Kim BH, Kim KH, et al.: In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae. J Ethnopharmacol 119, 145–152, 2008.
   PubMed Web of Science ®Google Scholar
• Lee MH, Choi HM, Hahm DH, Her E, Yang HI, et al.: Analgesic and anti-inflammatory effects in animal models of an ethanolic extract of Taheebo, the inner bark of Tabebuia avellanedae. Mol Med Rep 6, 791–796, 2012.
   PubMed Web of Science ®Google Scholar
• Souza MA, Johann S, Lima LA, Campos FF, Mendes IC, et al.: The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives. Mem Inst Oswaldo Cruz 108, 342–351, 2013.
   Web of Science ®Google Scholar
• Höfling JF, Anibal PC, Obando-Pereda GA, Peixoto IA, Furletti VF, et al.: Antimicrobial potential of some plant extracts against Candida species. Braz Biol 70, 1065–1068, 2010.
   PubMed Web of Science ®Google Scholar
• Dvorkin-Camiel L and Whelan JS: Tropical American plants in the treatment of infectious diseases. J Diet Suppl 5, 349–372, 2008.
   PubMedGoogle Scholar
• Cirillo N, Vicidomini A, McCullough M, Gambardella A, Hassona Y, et al.: A hyaluronic acid-based compound inhibits fibroblast senescence induced by oxidative stress in vitro and prevents oral mucositis in vivo. J Cell Physiol 230, 1421–1429, 2015.
   PubMed Web of Science ®Google Scholar
• Licitra L and Olmi P: Tumori della Testa e Collo. Milan: Italy, Springer, 2011.
   Google Scholar
• Bártíková H, Skálová L, Valentová K, Matoušková P, Szotáková B, et al.: Effect of oral administration of green tea extract in various dosage schemes on oxidative stress status of mice in vivo. Acta Pharm 65 65–73, 2015.
   PubMed Web of Science ®Google Scholar
• Reygaert W: The antimicrobial possibilities of green tea. Front Microbiol 20, 434, 2014.
   Google Scholar
• Babaee N, Moslemi D, Khalilpour M, Vejdani F, Moghadamnia Y, et al.: Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngealmucositis in patients with head and neck cancers: a randomized controlled clinical study. Daru 21, 18, 2013.
   PubMed Web of Science ®Google Scholar
• Stubbe CE and Valero M: Complementary strategies for the management of radiation therapy side effects. J Adv Pract Oncol 4, 219–231, 2013.
   PubMedGoogle Scholar
• Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, et al.: Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. Journal of Ethnopharmacology 64, 235–240, 1999.
   PubMed Web of Science ®Google Scholar
• Razavi SM, Zarrini G, Molavi G, and Ghasemi G: Bioactivity of malva sylvestris L., a medicinal plant from Iran. Iran J Basic Med Sci 14, 574–579, 2011.
   PubMed Web of Science ®Google Scholar
• Nancy L: A phase II study of concurrent chemoradiotherapy using three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) + bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer. RTOG 0615, 2011.
   Google Scholar
• Trotti A and Gillison M: A phase III trial of radiotherapy plus cetuximab versus chemoradiotherapy in HPV-associated oropharynx cancer. RTOG 1016, 2014.
   Google Scholar
• Ling IS, Larsson B, Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy. Support Care Cancer 19, 1343–1350, 2011.
   PubMed Web of Science ®Google Scholar
• Demarosi F, Bez C, and Carrassi A: Prevention and treatment of chemo- and radiotherapy-induced oral mucositis, Minerva Stomatol 51, 173–186, 2002.
   PubMedGoogle Scholar
• Worthington HV, Clarkson JE, Eden OB, Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 19(2), CD000978, 2006.
   Google Scholar
• Quinn B: Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data. Eur J Cancer Care (Engl) 22, 564–579, 2013.
   PubMed Web of Science ®Google Scholar
• Maguire PD, Papagikos M, Hamann S, Neal C, Meyerson M, et al.: Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer. J Radiat Oncol Biol Phys 79, 1081–1088, 2011.
   PubMed Web of Science ®Google Scholar
• Saigal K, Santos ES, Tolba K, Kwon D, and Elsayyad N: Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma. Front Oncol 30, 165, 2014.
   Google Scholar
• Tarnawski R, Fowler J, Skladowski K, Swierniak A, Suwiński R, et al.: How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys 54, 229–236, 2002.
   PubMed Web of Science ®Google Scholar
• Robertson C, Robertson AG, Hendry JH, Roberts SA, Slevin NJ et al.: Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40, 319–329, 1998.
   PubMed Web of Science ®Google Scholar
• Fowler JF and Lindstrom MJ: Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23, 457–467, 1992.
   PubMed Web of Science ®Google Scholar